Literature DB >> 11934603

Pathophysiology of viral myocarditis: the role of humoral immune response.

Bernhard Maisch1, Arsen D Ristić, Günter Hufnagel, Sabine Pankuweit.   

Abstract

The pathophysiology of viral myocarditis is still a matter of debate. Humoral autoimmunity in postviral heart disease remains an attractive but complex hypothesis. Antigenic mimicry with or without cytolytic antibody properties has been shown to play a role in the immunopathogenesis of myocarditis with respect to sarcolemmal/myolemmal epitopes (including the beta-receptor), myosin and some mitochondrial proteins including the antinucleotide translocator (ANT)-carrier and dihydrolipoamid dehydrogenase. Today, refined two-dimensional Western blots are able to identify receptors and enzymes that are target of a humoral immune response or the consequence of an "immunization process." A humoral immune response to an invading agent will most likely lead to immunodestruction first. After conversion to IgG, the continuing antibody response may indicate the healing or healed process and last for many years or life-long. This paper reviews our present knowledge on the humoral immune response in myocarditis and its interplay with the viral agents and the other components of the immune system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934603     DOI: 10.1016/s1054-8807(01)00113-2

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  22 in total

Review 1.  [Treatment of progressive heart failure: pharmacotherapy, resynchronization (CRT), surgery].

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Herz       Date:  2010-03       Impact factor: 1.443

2.  Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis.

Authors:  Dafei Chai; Yan Yue; Wei Xu; Chunsheng Dong; Sidong Xiong
Journal:  Hum Vaccin Immunother       Date:  2014-03-10       Impact factor: 3.452

3.  Acute hemorrhagic leukoencephalomyelitis in a man with viral myocarditis.

Authors:  Indira D Kitulwatte; Patrick J H Kim; Michael S Pollanen
Journal:  Forensic Sci Med Pathol       Date:  2015-07-08       Impact factor: 2.007

4.  Recurrent pericarditis in children: elevated cardiac autoantibodies.

Authors:  R Dalla Pozza; D Hartl; S Bechtold; S Urschel; R Kozlik-Feldmann; S Pankuweit; B Belohradsky; H Netz
Journal:  Clin Res Cardiol       Date:  2006-12-22       Impact factor: 5.460

Review 5.  Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.

Authors:  B Maisch; S Pankuweit
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

6.  Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease.

Authors:  Sean M O'Donnell; Mark W Hansberger; Jodi L Connolly; James D Chappell; Melissa J Watson; Janene M Pierce; J Denise Wetzel; Wei Han; Erik S Barton; J Craig Forrest; Tibor Valyi-Nagy; Fiona E Yull; Timothy S Blackwell; Jeffrey N Rottman; Barbara Sherry; Terence S Dermody
Journal:  J Clin Invest       Date:  2005-08-11       Impact factor: 14.808

Review 7.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

8.  Direct gene transfer with IP-10 mutant ameliorates mouse CVB3-induced myocarditis by blunting Th1 immune responses.

Authors:  Yan Yue; Jun Gui; Wenqing Ai; Wei Xu; Sidong Xiong
Journal:  PLoS One       Date:  2011-03-22       Impact factor: 3.240

9.  Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo.

Authors:  Roberta L DeBiasi; Bridget A Robinson; Barbara Sherry; Ron Bouchard; R Dale Brown; Mona Rizeq; Carlin Long; Kenneth L Tyler
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failure.

Authors:  Uichi Ikeda; Hiroki Kasai; Atsushi Izawa; Jun Koyama; Yoshikazu Yazaki; Masafumi Takahashi; Makoto Higuchi; Chang-Sung Koh; Keiji Yamamoto
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.